** Summit Therapeutics is seeking an Executive Director for US Market Access Strategy to lead the value strategy for the launch of Ivonescimab in oncology. The role requires extensive experience in market access, particularly within oncology, and involves collaboration across multiple departments to ensure successful product uptake and patient access. **
Base: $245,000 - $307,000 USD; Bonus/Equity: Not specified; Benefits: Not specified
Must-have
Nice-to-have
Not specified